Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) declared a dividend on Saturday, March 15th, NASDAQ Dividends reports. Stockholders of record on Friday, April 11th will be paid a dividend of 0.2909 per share on Thursday, June 5th. The ex-dividend date of this dividend is Friday, April 11th. This is a 51.9% increase from Reckitt Benckiser Group’s previous dividend of $0.19.
Reckitt Benckiser Group Price Performance
Shares of Reckitt Benckiser Group stock opened at $13.33 on Monday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $14.10. The company has a 50 day simple moving average of $12.98 and a two-hundred day simple moving average of $12.48.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the company. Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Hsbc Global Res raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Barclays downgraded shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 4th. Finally, HSBC raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Three equities research analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- 5 discounted opportunities for dividend growth investors
- 3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
- Following Congress Stock Trades
- EU-U.S. Military Shift: A Catalyst for These 3 Stocks
- The How and Why of Investing in Gold Stocks
- How to Build the Ultimate Everything ETF Portfolio
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.